SFG
GILD icon

Steward Financial Group’s Gilead Sciences GILD Stock Holding History

Steward Financial Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$30K Buy
409
+1
+0.2% +$77 0.01% 199
2023
Q2 		$31K Buy
+408
New +$32.5K 0.01% 191
2022
Q3 		– Sell
-149
Closed -$9K – 569
2022
Q2 		$9K Buy
+149
New +$9.22K 0.01% 255

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Steward Financial Group's GILD Position: Q3 2023 in Review

Steward Financial Group increased its Gilead Sciences (GILD) stake by 0.25% in Q3 2023, buying an estimated $77 and bringing the position to 409 shares worth $30K. The position accounts for 0.01% of the portfolio, ranked #199.

Steward Financial Group first reported a position in GILD in Q2 2022 and has held it in 3 quarters since. The position peaked at $31K in Q2 2023. 1,681 funds tracked by Wall St. Rank hold GILD as of Q3 2023.

  • Steward Financial Group held 409 shares of Gilead Sciences worth $30K as of Q3 2023.
  • Steward Financial Group bought 1 Gilead Sciences share in Q3 2023, an estimated $77.
  • Gilead Sciences made up 0.01% of Steward Financial Group's portfolio in Q3 2023, its #199 holding.
  • Steward Financial Group first reported a position in Gilead Sciences in Q2 2022 and has held it in 3 quarters since.
  • Steward Financial Group's Gilead Sciences position peaked at $31K in Q2 2023.
  • 1,681 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.